|
|
Clinical observation of endoscopic ultrasound minimally invasive treatment for upper gastrointestinal submucosal tumors |
ZHENG Fengfan PENG Tao |
Endoscopy Center, the First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China |
|
|
Abstract Objective To explore the effect of endoscopic ultrasound minimally invasive treatment for upper gastrointestinal submucosal tumors. Methods A total of 174 cases with upper gastrointestinal submucosal tumors in the First Affiliated Hospital of Hebei North University from September 2017 to September 2019 were selected as research objects. All patients underwent endoscopic mucosal dissection. The nature, origin and distribution of upper gastrointestinal submucosal tumors were observed. The diagnostic coincidence rate of digestive endoscopy was observed, pathological diagnosis as the “gold standard”. The levels of serum tumor markers including carbohydrate antigen (CA)15-3, carcinoembryonic antigen (CEA), CA19-9 and tumour-specific growth factor were compared before and after treatment. The incidence of complications was recorded. Results Esophageal leiomyoma is the most common esophageal lesion, mainly distributed in the lower thoracic segment and upper thoracic segment, mostly originated from the muscular mucosa, and the echo characteristic is hypoecho. The diagnostic coincidence rate of endoscopic ultrasound was 99.42%. The levels of CA15-3, CEA, CA19-9 and tumor-specific growth factor after treatment were lower than those before treatment, with statistical significance (all P < 0.05). After minimally invasive treatment, nine patients developed obvious epigastric pain or retrosternal pain 24 h after surgery, three patients developed perforation, and seven patients developed significant postoperative bleeding. All patients were improved after targeted treatment. Conclusion Endoscopic ultrasound minimally invasive treatment for upper gastrointestinal submucosal tumors can not only help the clinical diagnosis of patients, but also provide corresponding treatment, with few complications and high safety, which is worthy of application and promotion.
|
|
|
|
|
[1] 刘赛楠.早期上消化道肿瘤行内镜下黏膜剥离术治疗护理体会[J].山西医药杂志,2020,49(1):115-117.
[2] 朴莲淑,刘汉英,姜哲,等.微探头超声内镜在上消化道固有肌层黏膜下肿瘤定性定位诊断中的应用价值[J].现代消化及介入诊疗,2020,25(1):124-126.
[3] 赵治彬,孔宏芳,王娟.内镜经黏膜下隧道肿瘤切除术治疗上消化道黏膜下肿瘤的临床研究[J].中国内镜杂志,2018,24(12):104-107.
[4] 田雪丽,黄永辉,李渊,等.内镜经黏膜下隧道肿瘤切除术治疗源于固有肌层的上消化道黏膜下肿瘤[J].中国内镜杂志,2018,24(12):90-94.
[5] 田雪丽,黄永辉,姚炜,等.上消化道固有肌层肿瘤经内镜黏膜下隧道肿瘤切除术和黏膜下肿瘤挖除术的治疗对比[J].北京大学学报:医学版,2019,51(1):171-176.
[6] 曾婷.上消化道黏膜下肿瘤采用内镜下尼龙绳套扎术治疗的围术期护理[J].实用临床医药杂志,2019,23(4):20-22.
[7] 徐刚.超声内镜在上消化道黏膜下肿瘤诊治中的临床价值[J].实用癌症杂志,2018,33(10):1686-1689.
[8] 张春燕.内镜下黏膜剥离术治疗上消化道肿瘤的护理配合[J].护理实践与研究,2018,15(18):18-19.
[9] 薛麟,华鹏,高原.内镜黏膜下剥离术和切除术对早期上消化道肿瘤的疗效比较[J].实用癌症杂志,2018,33(10):1690-1692.
[10] 鲁花,范秀平.早期上消化道肿瘤患者内镜下黏膜剥离术前后心理焦虑和抑郁变化及影响因素[J].中国健康心理学杂志,2019,27(5):715-718.
[11] 胡玲珍,陈志芬.上消化道黏膜下肿瘤内镜诊疗进展[J].现代肿瘤医学,2018,26(10):1603-1607.
[12] 高蕾,周真真.EUS结合STER在上消化道固有肌层黏膜下肿瘤治疗中的应用效果[J].安徽医学,2019,40(6):631-634.
[13] 屈卫翔,杨光朝,祁金峰,等.超声内镜用于食管胃底静脉曲张断流术的指导意义[J].中国医药科学,2020,10(19):232-235.
[14] 刘雪,林晔,蔡洪,等.超声胃镜联合磁共振对胰腺导管内乳头状黏液瘤的诊断价值[J].中国现代医生,2020, 58(33):9-12.
[15] 马丹,张澍田,张倩,等.以胃间质瘤为初诊患者行内镜下治疗后的病理符合情况[J].临床和实验医学杂志,2019, 18(17):1864-1866.
[16] 李利娟,李娟,孙苗苗,等.超声内镜在早期胃癌及胃黏膜下良性肿瘤诊断中的应用分析[J].现代消化及介入诊疗,2020,25(7):958-961.
[17] 薛仕贵.上消化道固有肌层肿瘤经内镜黏膜下隧道肿瘤切除效果与患者APACHEⅡ评分及预后的关系[J].中国中西医结合消化杂志,2019,27(4):289-293,297.
[18] 王建锋,王耿泽,宋展,等.内镜黏膜下隧道法剥离术与内镜黏膜下剥离术治疗上消化道黏膜下肿瘤的对比研究[J].中华消化内镜杂志,2018,35(5):361-363.
[19] 彭金榜,叶丽萍,毛鑫礼,等.上消化道黏膜下肿瘤1237例次的病理学特征和分布特点[J].中华消化杂志,2019,39(2):94-99.
[20] 严欢,和水祥,王淑英,等.超声内镜对消化道神经内分泌肿瘤的诊断价值[J].西安交通大学学报:医学版,2020, 41(5):738-741.
[21] 徐红燕,李生,丁百静.小探头超声内镜对上消化道肿瘤T分期的价值分析[J].现代消化及介入诊疗,2020, 25(5):670-673.
[22] 雷蕾,肖迅,张志宏,等.超声内镜检查联合血清嗜铬粒素A检测对消化道神经内分泌肿瘤的诊断价值[J].广西医学,2020,42(10):1208-1211.
[23] 周雪莎,刘鹏.内镜治疗消化道肿瘤的研究进展[J].现代消化及介入诊疗,2020,25(2):262-265.
[24] 马海蓉,韩孟营,高云云,等.上消化道固有肌层肿瘤特点及内镜下治疗分析[J].中国实验诊断学,2020,24(3):429-433.
[25] 林明芳.安全预警护理在内镜下切除上消化道黏膜下肿瘤中的应用及效果分析[J].中外医学研究,2019,17(32):82-84.
[26] 陈锐娜,李桂宝,彭樱花,等.优质护理在上消化道超声内镜检查中的应用效果[J].中国当代医药,2020,27(5):216-218.
[27] Liu F,Gao Z,Shen H,et al. Significance of SATB2 expression in colon cancer and its differential diagnosis in digestive tract adenocarcinoma and ovarian primary and metastatic carcinoma [J]. Pathol Res Pract,2019,215(7):152430.
[28] Yokozaki H,Koma YI,Shigeoka M,et al. Cancer as a tissue:The significance of cancer-stromal interactions in the development,morphogenesis and progression of human upper digestive tract cancer [J]. Pathol Int,2018,68(6):334-352.
[29] Gibson WE,Gonzalez RS,Cates JMM,et al. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract [J]. Hum Pathol,2018,79:109-115.
[30] Begum FA,Rahman MA,Rabbi H,et al. Primary Jejunal Gastrointestinal Stromal Tumor:Diagnosis Delay of 3 Years but Successful Management in Early Stage(Ⅱ)by Surgery and Adjuvant Therapy [J]. Gastrointest tumors,2019,6(1/2):36-42. |
|
|
|